« Get in the circle  | Main  | Tapping into the universal benefits of exercise »

Welcome to alliconnect, year two

Hello. I’m Karen Scollick and I’m pleased to be leading the new Behavioral Science team for GSK Consumer Healthcare, which includes alli as well as our smoking control products.  As I mentioned in my bio, I enjoy sailing and I see a number of parallels between sailing and my new role.

Christopher Columbus stated, “By prevailing over all obstacles and distractions, one may unfailingly arrive at his chosen goal or destination.” As we have celebrated alli’s first birthday this summer, we have heard from hundreds of alli users who are transforming their lives. Many of these stories are captured in our just-launched allicircles community as well as our special anniversary book, “we lost it.”

Behind the images and stories that summarize these journeys exist poignant recounts of challenges that have been faced, from overcoming cravings and other temptations to managing treatment effects and increasing simple daily activity levels. We can all learn and grow from their candid comments.

Whether your weight loss journey has been smooth sailing all the way or with periods of choppy waters, my team and I would like to hear from you. We can all learn and grow together on the alli journey toward a healthy body and lifestyle.

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.

 

   

 

Post

about this blog

  • alliConnect is GlaxoSmithKline's official corporate blog for alli, the only FDA-approved, OTC weight loss product. It's a place for you to have a conversation with us about weight loss issues. Because we work for a drug company we do have to abide by a few rules. Legal stuff...

Subscribe

  • RSS feed

    Enter your email address below to receive an email whenever a new entry is published.

comments policy

  • We want to hear from you! We review all comments in advance. Please stay on topic, be respectful of others' views and avoid profanity. More about our comments policy

Search this blog

Go

About the authors

contact us

about gsk